Skip to main content
Site Logo
Research and publications
Allergy, asthma and lung
Big data methods
Bone, joint and muscle
Cancer
Climate and environment
Comparative effectiveness
Diabetes
Health economics
Health system and policy
Hearing and vision
Heart and stroke
Infectious disease
Kidney, liver, pancreas and stomach
Mental health and substance use disorders
Opioids and pain management
Pediatric health
Special populations and aging issues
Women's health
See all
Qualified Entity Program
Partners
Research and publications
Allergy, asthma and lung
Big data methods
Bone, joint and muscle
Cancer
Climate and environment
Comparative effectiveness
Diabetes
Health economics
Health system and policy
Hearing and vision
Heart and stroke
Infectious disease
Kidney, liver, pancreas and stomach
Mental health and substance use disorders
Opioids and pain management
Pediatric health
Special populations and aging issues
Women's health
See all
Qualified Entity Program
Partners
Home
Section
April 3, 2025
The effect of a post-bronchodilator FEV1/FVC<0.7 on COPD diagnosis and treatment: a regression discontinuity design.
Moffett A, Halpern S, Weissman G. Respiratory Research. (UPenn)
View publication
keyboard_arrow_up
back to top
back to top
keyboard_arrow_up
